PMID: 7546265Aug 1, 1995Paper

Pelvic abscess induced by a methicillin-resistant Staphylococcus aureus from haematogenous spread via the CVP line in a burn patient

Burns : Journal of the International Society for Burn Injuries
T W Lin, C H Liu

Abstract

A 38-year-old female patients was found accidentally to have a positive culture of MRSA from a routine CVP catheter tip culture 1 week after she had complete wound closure. She was recovering from a partial skin thickness burn covering 42 per cent TBSA on the trunk and extremities. Fever and hip pain developed abruptly 1 week later when she was ready for discharge from hospital. Magnetic resonance imaging (MRI) of the pelvis disclosed an intramuscular abscess. Open drainage was performed and pus culture yielded a MRSA with the same sensitivity profile as the previous CVP tip culture. Vancomycin 500 mg every 6 h was used for 3 weeks until the drain culture disclosed a negative result, and a follow-up MRI indicated a loss of the abscess space. Follow-up at an outpatient clinic 3 months later showed that the patient remained symptom free. In this patient haematogenous dissemination was the most likely route of pelvic abscess formation. It should be remembered that MRSA infection is not always only a local problem, especially in the immunocompromised condition of burn injury.

References

Jul 1, 1992·The Journal of Burn Care & Rehabilitation·T SuzukiO Kawanami
Mar 1, 1992·The Journal of Burn Care & Rehabilitation·L G PhillipsM C Robson
May 4, 1989·The New England Journal of Medicine·W Brumfitt, J Hamilton-Miller
Nov 9, 1989·The New England Journal of Medicine
May 1, 1987·The Journal of Infectious Diseases·J BlackE Matthew

❮ Previous
Next ❯

Citations

Jul 26, 2011·American Journal of Obstetrics and Gynecology·Charles H FengPhilip A Higginbottom

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.